Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Harvard team succeeds in promoting angiogenesis in coronary arteries

Nov. 2, 1999

CGS-35066: potent and specific ECE inhibitor presented at ET-6

Nov. 2, 1999

New type III antiarrhythmic marketed in Japan

Nov. 2, 1999

AGI-1067 and related AtheroGenics compounds licensed to Schering-Plough

Oct. 29, 1999

ETA/ETB antagonist tezosentan is a promising parenteral treatment for acute conditions

Oct. 29, 1999

Scios begins patient enrollment in phase III Natrecor trial

Oct. 28, 1999

Ion channel-blocking antiarrhythmic and anesthetic agents from Nortran

Oct. 28, 1999

Increasing NO levels in blood as novel strategy for sickle cell disease

Oct. 21, 1999

Texas Biotechnology announces new preclinical, clinical data and future plans for sitaxsentan

Oct. 19, 1999

Teveten now available in the U.S.

Oct. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...